Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer

NCT07702708 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

HR+/HER2- Breast Cancer
Breast Neoplasms

Interventions

DIAGNOSTIC_TEST: Pre-treatment DCE-MRI-based AI model

Sponsor

Fujian Cancer Hospital